latest news releases from the newsroom
Crucell and DSM Announce PER.C6 Licensing Agreement with Chiron
LEIDEN, Netherlands, Aug. 16, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and allied contract manufacturer DSM Biologics announced today that they have signed a PER.C6(R) research license agreement for recombinant protein production with Chiron Corporation. This new agreement allows Chiron to evaluate the PER.C6(R) cell line for use in the manufacturing of Chiron's prophylactic hepatitis C vaccine, which is currently in phase I clinical trials.
Medicover Acquires Polish Laboratory Business Based in Lodz
STOCKHOLM, Sweden, Aug. 16, 2005 (PRIMEZONE) -- Medicover has acquired a Polish laboratory business, Laboratorium Medyczne "Eurolab" Sp. z o.o. for an undisclosed amount. Eurolab is a large, quality accredited laboratory located in Lodz, central Poland. Fredrik Ragmark, Medicover's Managing Director stated that, "Medicover is extending its human diagnostic laboratory activities in Poland building on the base that has been established over the last 2 years. We will see further synergies coming from this acquisition and a strengthening of the operational resources of Synevo. We expect to see further acquisition and expansion opportunities in the coming 12 to 18 months." The laboratory activities of Medicover trade under the name Synevo in Poland and Romania.
Medicore, Inc. Reports Second Quarter 2005 Results
HIALEAH, Fla., Aug. 15, 2005 (PRIMEZONE) -- Medicore, Inc. (Nasdaq:MDKI) announced financial results for the first half of 2005. Operating revenues for the second quarter of 2005 increased 16% to $11,339,000 compared to $9,788,000 for the same period last year. Operating revenues for the first half of 2005 increased 19% to $22,148,000 compared to $18,639,000 for the same period last year.
Roberts Realty Investors, Inc.
Roberts Realty Investors, Inc. Selects Independent Auditor
ATLANTA, Aug. 15, 2005 (PRIMEZONE) -- Roberts Realty Investors, Inc. (AMEX:RPI) announced that the audit committee of its board of directors has selected Reznick Group to replace Deloitte & Touche as its independent auditor, effective August 12. Reznick was selected after a thorough search process that began after Deloitte announced in June that it intended to resign as the company's independent auditor, upon conclusion of its review of the company's interim financial information for the quarter ended June 30, 2005. Deloitte completed that review on August 12. The resignation of Deloitte was not the result of any disagreement between the company and Deloitte on any matter of accounting principles, practices, auditing scope or procedure or financial statement disclosures.
Telestone Technology Corp.
Telestone Technologies Reports Second Quarter Results
NEW YORK, Aug. 15, 2005 (PRIMEZONE) -- Telestone Technologies Corporation (AMEX:TST) today announced that, for the second quarter ended June 30, 2005, it achieved revenues of $4,404,000, a 14 percent increase on revenues of $3,869,000 for the same period a year ago. Telestone's net income for the 2005 second quarter was $784,000, or $.08 per fully diluted share, compared to net income of $1,443,000, or $.18 per fully diluted share, for the corresponding period in 2004.
NuVim, Inc. Announces Expansion of Its Wal-Mart Distribution Test Program
PARAMUS, N.J., Aug. 15, 2005 (PRIMEZONE) -- NuVim, Inc. (OTCBB:NUVM) announced today that Wal-Mart has recently expanded its test of NuVim(r) beverages at Wal-Mart. The expansion is from one Wal-Mart distribution center that services approximately 43 Wal-Mart Supercenters in the state of Florida to an additional Wal-Mart distribution center servicing approximately 40 more Supercenters.